Mismatch negativity: a simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR) -type glutamate dysfunction in schizophrenia
Avissar, M.; Javitt, D.
Schizophrenia Research 191: 1-4
2018
ISSN/ISBN: 1573-2509 PMID: 29132813 DOI: 10.1016/j.schres.2017.11.006
Accession: 059975500
Full Text Article emailed within 0-6 h: $19.90
Related References
Javitt, D.C.; Kantrowitz, J.T. 2022: The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: on the path from syndrome to disease Schizophrenia Research 242: 56-61Hamilton, H.K.; D'Souza, D.C.; Ford, J.M.; Roach, B.J.; Kort, N.S.; Ahn, K.-H.; Bhakta, S.; Ranganathan, M.; Mathalon, D.H. 2018: Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia Schizophrenia Research 191: 87-94
Tachibana, N.; Shirakawa, T.; Ishii, K.; Takahashi, Y.; Tanaka, K.; Arima, K.; Yoshida, T.; Ikeda, S.-I. 2010: Expression of various glutamate receptors including N-methyl-D-aspartate receptor (NMDAR) in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis Internal Medicine 49(19): 2167-2173
Catts, V.S.; Lai, Y.L.; Weickert, C.S.; Weickert, T.W.; Catts, S.V. 2016: A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: how can we link molecular abnormalities to mismatch negativity deficits? Biological Psychology 116: 57-67
Javitt, D.C.; Lee, M.; Kantrowitz, J.T.; Martinez, A. 2018: Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia Schizophrenia Research 191: 51-60
Steiner, J.; Walter, M.; Glanz, W.; Sarnyai, Z.án.; Bernstein, H.-G.; Vielhaber, S.; Kästner, A.; Skalej, M.; Jordan, W.; Schiltz, K.; Klingbeil, C.; Wandinger, K.-P.; Bogerts, B.; Stoecker, W. 2013: Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis JAMA Psychiatry 70(3): 271-278
Javitt, D.C.; Steinschneider, M.; Schroeder, C.E.; Arezzo, J.C. 1996: Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia Proceedings of the National Academy of Sciences of the United States of America 93(21): 11962-11967
Bowers, M.S.; Cacheaux, L.P.; Sahu, S.U.; Schmidt, M.E.; Sennello, J.A.; Leaderbrand, K.; Khan, M.A.; Kroes, R.A.; Moskal, J.R. 2020: NYX-2925 induces metabotropic N-methyl-d-aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor Journal of Neurochemistry 152(5): 523-541
Ju, P.; Cui, D. 2016: The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia Acta Biochimica et Biophysica Sinica 48(3): 209-219
Chitty, K.M.; Lagopoulos, J.; Kaur, M.; Hickie, I.B.; Hermens, D.F. 2015: The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study International Journal of Neuropsychopharmacology 18(6)
Dean, B.J.F.; Snelling, S.J.B.; Dakin, S.G.; Javaid, M.K.; Carr, A.J. 2015: In vitro effects of glutamate and N-methyl-D-aspartate receptor (NMDAR) antagonism on human tendon derived cells Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 33(10): 1515-1522
Kantrowitz, J.T. 2019: N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia Schizophrenia Research 207: 70-79
Lin, E.; Lin, C.-H.; Hung, C.-C.; Lane, H.-Y. 2020: An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways Frontiers in Bioengineering and Biotechnology 8: 569
Huang, Y.H.; Lin, Y.; Brown, T.E.; Han, M.-H.; Saal, D.B.; Neve, R.L.; Zukin, R.S.; Sorg, B.A.; Nestler, E.J.; Malenka, R.C.; Dong, Y. 2008: CREB modulates the functional output of nucleus accumbens neurons: a critical role of N-methyl-D-aspartate glutamate receptor (NMDAR) receptors Journal of Biological Chemistry 283(5): 2751-2760
Xuan, Z.; Barthet, G.; Shioi, J.; Xu, J.; Georgakopoulos, A.; Bruban, J.; Robakis, N.K. 2013: Presenilin-1/γ-secretase controls glutamate release, tyrosine phosphorylation, and surface expression of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B Journal of Biological Chemistry 288(42): 30495-30501
Kantrowitz, J.; Epstein, M.; Beggel, O.; Rohrig, S.; Lehrfeld, J.; Revheim, N.; Lehrfeld, N.; Reep, J.; Parker, E.; Silipo, G.; Ahissar, M.; Javitt, D. 2017: Neurophysiological Mechanisms of Cortical Learning Plasticity Impairments in Schizophrenia and Modulation by the N-Methyl-D-Aspartate Type Glutamate Receptor Agonist D-Serine Biological Psychiatry 81(10): S174-S175
Seo, J.; Zheng, Y.; Hagen, S.J. 2010: S1655 Helicobacter pylori Ammonia Causes N-Methyl-D-Aspartate Receptor (Nmdar) Activation, Calcium Influx, and Ip3 Receptor-Mediated Mitochondrial Damage to Gastric Epithelial Cells That Can Be Blocked by Nmdar Antagonists Gastroenterology 138(5): S-247
Kantrowitz, J.T.; Swerdlow, N.R.; Dunn, W.; Vinogradov, S. 2018: Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: a Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function Biological Psychiatry. Cognitive Neuroscience and Neuroimaging 3(7): 581-590
Di Maria, E.; Gulli, R.; Pioli, R.; De Luca, A.; Novelli, G.; Gennarelli, M.; Mandich, P. 2001: Glutamate hypothesis of schizophrenia No evidence that the N-methyl-D-aspartate receptor 2B gene is associated with susceptibility to schizophrenia American Journal of Medical Genetics 105(7): 621-622
Scianni, M.; Antonilli, L.; Chece, G.; Cristalli, G.; Di Castro, M.A.; Limatola, C.; Maggi, L. 2013: Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity Journal of Neuroinflammation 10: 108